Clinical Trials Logo

Clinical Trial Summary

The investigators' data from a phase I study of short course radiation therapy followed by chemotherapy showed 74% complete clinical response (cCR). Given the promising response rate, the investigators are evaluating short course radiation therapy (SCRT) followed by chemotherapy in a multi-institution phase II trial to validate the cCR rate of this treatment paradigm. SCRT has not been prospectively evaluated in non-operative management for patients with non-metastatic rectal adenocarcinoma.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03904043
Study type Interventional
Source Washington University School of Medicine
Contact Hyun Kim, M.D.
Phone 314-362-8502
Email kim.hyun@wustl.edu
Status Recruiting
Phase N/A
Start date July 1, 2020
Completion date June 30, 2026